oxiracetam has been researched along with Dementia, Vascular in 2 studies
oxiracetam: structure in first source
Dementia, Vascular: An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxiracetam (ORC) is a commonly used nootropic drug for improving cognition and memory impairments." | 1.51 | Oxiracetam ameliorates cognitive deficits in vascular dementia rats by regulating the expression of neuronal apoptosis/autophagy-related genes associated with the activation of the Akt/mTOR signaling pathway. ( Dong, Y; Jiang, X; Liu, Z; Lv, P; Qi, Q; Xu, J, 2019) |
| "Oxiracetam is a nootropic drug that is commonly used to treat cognitive deficits of cerebrovascular origins." | 1.46 | (S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats. ( Guo, Y; Jiang, H; Li, W; Liu, H; Nie, Z; Pu, X; Sun, Y; Wang, C; Xiong, X; Zhang, K; Zhang, X; Zhao, X, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, J | 1 |
| Qi, Q | 1 |
| Lv, P | 1 |
| Dong, Y | 1 |
| Jiang, X | 1 |
| Liu, Z | 1 |
| Li, W | 1 |
| Liu, H | 1 |
| Jiang, H | 1 |
| Wang, C | 1 |
| Guo, Y | 1 |
| Sun, Y | 1 |
| Zhao, X | 1 |
| Xiong, X | 1 |
| Zhang, X | 1 |
| Zhang, K | 1 |
| Nie, Z | 1 |
| Pu, X | 1 |
2 other studies available for oxiracetam and Dementia, Vascular
| Article | Year |
|---|---|
Oxiracetam ameliorates cognitive deficits in vascular dementia rats by regulating the expression of neuronal apoptosis/autophagy-related genes associated with the activation of the Akt/mTOR signaling pathway.
Topics: Animals; Apoptosis; Autophagy; Cognitive Dysfunction; Dementia, Vascular; Disease Models, Animal; Ma | 2019 |
(S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Astrocytes; Cerebral Cortex; Cerebrovascular Circulat | 2017 |